ACR Appropriateness Criteria® Resectable Stomach Cancer

Parima Daroui, Salma K. Jabbour, Joseph M. Herman, May Abdel-Wahab, Nilofer Azad, A. William Blackstock, Prajnan Das, Karyn A. Goodman, Theodore S. Hong, William E. Jones, Harmeet Kaur, Andre A. Konski, Albert C. Koong, Rachit Kumar, Timothy M. Pawlik, William Small, Charles Thomas, W. Warren Suh

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

For resectable gastric cancer, perioperative chemotherapy or adjuvant chemoradiation with chemotherapy are standards of care. The decision making for adjuvant therapeutic management can depend on the stage of the cancer, lymph node positivity, and extent of surgical resection. After gastric cancer resection, postoperative chemotherapy combined with chemoradiation should be incorporated in cases of D0 lymph node dissection, positive regional lymph nodes, poor clinical response to induction chemotherapy, or positive margins. In the setting of a D2 lymph node dissection, especially those with negative regional lymph nodes, adjuvant chemotherapy alone could be considered. The American College of Radiology (ACR) Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Original languageEnglish (US)
JournalOncology (Williston Park, N.Y.)
Volume29
Issue number8
StatePublished - Aug 1 2015

Fingerprint

Radiology
Stomach Neoplasms
Lymph Nodes
Adjuvant Chemotherapy
Lymph Node Excision
Guidelines
Drug Therapy
Induction Chemotherapy
Expert Testimony
Standard of Care
Consensus
Decision Making
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Daroui, P., Jabbour, S. K., Herman, J. M., Abdel-Wahab, M., Azad, N., Blackstock, A. W., ... Suh, W. W. (2015). ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park, N.Y.), 29(8).

ACR Appropriateness Criteria® Resectable Stomach Cancer. / Daroui, Parima; Jabbour, Salma K.; Herman, Joseph M.; Abdel-Wahab, May; Azad, Nilofer; Blackstock, A. William; Das, Prajnan; Goodman, Karyn A.; Hong, Theodore S.; Jones, William E.; Kaur, Harmeet; Konski, Andre A.; Koong, Albert C.; Kumar, Rachit; Pawlik, Timothy M.; Small, William; Thomas, Charles; Suh, W. Warren.

In: Oncology (Williston Park, N.Y.), Vol. 29, No. 8, 01.08.2015.

Research output: Contribution to journalReview article

Daroui, P, Jabbour, SK, Herman, JM, Abdel-Wahab, M, Azad, N, Blackstock, AW, Das, P, Goodman, KA, Hong, TS, Jones, WE, Kaur, H, Konski, AA, Koong, AC, Kumar, R, Pawlik, TM, Small, W, Thomas, C & Suh, WW 2015, 'ACR Appropriateness Criteria® Resectable Stomach Cancer', Oncology (Williston Park, N.Y.), vol. 29, no. 8.
Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW et al. ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park, N.Y.). 2015 Aug 1;29(8).
Daroui, Parima ; Jabbour, Salma K. ; Herman, Joseph M. ; Abdel-Wahab, May ; Azad, Nilofer ; Blackstock, A. William ; Das, Prajnan ; Goodman, Karyn A. ; Hong, Theodore S. ; Jones, William E. ; Kaur, Harmeet ; Konski, Andre A. ; Koong, Albert C. ; Kumar, Rachit ; Pawlik, Timothy M. ; Small, William ; Thomas, Charles ; Suh, W. Warren. / ACR Appropriateness Criteria® Resectable Stomach Cancer. In: Oncology (Williston Park, N.Y.). 2015 ; Vol. 29, No. 8.
@article{135d9fff9c2b40e8ac4aa521193e2a15,
title = "ACR Appropriateness Criteria{\circledR} Resectable Stomach Cancer",
abstract = "For resectable gastric cancer, perioperative chemotherapy or adjuvant chemoradiation with chemotherapy are standards of care. The decision making for adjuvant therapeutic management can depend on the stage of the cancer, lymph node positivity, and extent of surgical resection. After gastric cancer resection, postoperative chemotherapy combined with chemoradiation should be incorporated in cases of D0 lymph node dissection, positive regional lymph nodes, poor clinical response to induction chemotherapy, or positive margins. In the setting of a D2 lymph node dissection, especially those with negative regional lymph nodes, adjuvant chemotherapy alone could be considered. The American College of Radiology (ACR) Appropriateness Criteria{\circledR} are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.",
author = "Parima Daroui and Jabbour, {Salma K.} and Herman, {Joseph M.} and May Abdel-Wahab and Nilofer Azad and Blackstock, {A. William} and Prajnan Das and Goodman, {Karyn A.} and Hong, {Theodore S.} and Jones, {William E.} and Harmeet Kaur and Konski, {Andre A.} and Koong, {Albert C.} and Rachit Kumar and Pawlik, {Timothy M.} and William Small and Charles Thomas and Suh, {W. Warren}",
year = "2015",
month = "8",
day = "1",
language = "English (US)",
volume = "29",
journal = "ONCOLOGY (United States)",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "8",

}

TY - JOUR

T1 - ACR Appropriateness Criteria® Resectable Stomach Cancer

AU - Daroui, Parima

AU - Jabbour, Salma K.

AU - Herman, Joseph M.

AU - Abdel-Wahab, May

AU - Azad, Nilofer

AU - Blackstock, A. William

AU - Das, Prajnan

AU - Goodman, Karyn A.

AU - Hong, Theodore S.

AU - Jones, William E.

AU - Kaur, Harmeet

AU - Konski, Andre A.

AU - Koong, Albert C.

AU - Kumar, Rachit

AU - Pawlik, Timothy M.

AU - Small, William

AU - Thomas, Charles

AU - Suh, W. Warren

PY - 2015/8/1

Y1 - 2015/8/1

N2 - For resectable gastric cancer, perioperative chemotherapy or adjuvant chemoradiation with chemotherapy are standards of care. The decision making for adjuvant therapeutic management can depend on the stage of the cancer, lymph node positivity, and extent of surgical resection. After gastric cancer resection, postoperative chemotherapy combined with chemoradiation should be incorporated in cases of D0 lymph node dissection, positive regional lymph nodes, poor clinical response to induction chemotherapy, or positive margins. In the setting of a D2 lymph node dissection, especially those with negative regional lymph nodes, adjuvant chemotherapy alone could be considered. The American College of Radiology (ACR) Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

AB - For resectable gastric cancer, perioperative chemotherapy or adjuvant chemoradiation with chemotherapy are standards of care. The decision making for adjuvant therapeutic management can depend on the stage of the cancer, lymph node positivity, and extent of surgical resection. After gastric cancer resection, postoperative chemotherapy combined with chemoradiation should be incorporated in cases of D0 lymph node dissection, positive regional lymph nodes, poor clinical response to induction chemotherapy, or positive margins. In the setting of a D2 lymph node dissection, especially those with negative regional lymph nodes, adjuvant chemotherapy alone could be considered. The American College of Radiology (ACR) Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guideline development and review includes an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

UR - http://www.scopus.com/inward/record.url?scp=85047592944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047592944&partnerID=8YFLogxK

M3 - Review article

C2 - 26281845

AN - SCOPUS:84939511771

VL - 29

JO - ONCOLOGY (United States)

JF - ONCOLOGY (United States)

SN - 0890-9091

IS - 8

ER -